2m 2m 2m 2m 2m 2m 2m
Enanta Pharm (ENTA)
NASDAQ
$13.64-$0.005 (-0.04%)
Price as of Jul 13, 2026 6:18 PM EDT- $396.6MMarket Cap
- 95.98%1-Year Change
- BiotechnologyIndustry
Enanta Pharm (ENTA)
$13.64-$0.005 (-0.04%)
ENTA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.64 | ||
Change | -$0.06 (-0.44%) | ||
Open | $13.60 | ||
High | $13.97 | ||
Low | $13.43 | ||
Previous Close | $13.70 | ||
Volume | 139,402 | ||
30-Day Average Volume | 265,422 | ||
1-Week Change | -6.00% | ||
1-Month Change | 14.62% | ||
1-Year Change | 95.98% | ||
3-Year Change | -28.96% | ||
5-Year Change | -67.43% | ||
Fundamentals | |||
Shares Outstanding | 29.1M | ||
Total Assets | $314.7M | ||
Market Cap | $396.6M | ||
Enterprise Value | $361.7M | ||
Period: QTR TTM FY | |||
Revenue | $17.2M | ||
Net Income | -$13.1M | ||
Free Cash Flow | -$7.2M | ||
EBIT | -$9.8M | ||
EBITDA | -$8.6M | ||
Net Working Capital | $132.0M | ||
EPS | -$0.45 | ||
Enterprise Value/EBITDA | -42 | ||
Enterprise Value/Revenue | 21 | ||
P/B | 3 | ||
P/E | -30 | ||
PEG | 4 | ||
Price/Free Cash Flow | -55 | ||
Price/Operating Cash Flow | -55 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue